Literature DB >> 28648106

Pressure Autoregulation Measurement Techniques in Adult Traumatic Brain Injury, Part I: A Scoping Review of Intermittent/Semi-Intermittent Methods.

Frederick A Zeiler1,2,3, Joseph Donnelly4, Leanne Calviello4, David K Menon1, Peter Smielewski4, Marek Czosnyka4.   

Abstract

The purpose of this study was to perform a systematic, scoping review of commonly described intermittent/semi-intermittent autoregulation measurement techniques in adult traumatic brain injury (TBI). Nine separate systematic reviews were conducted for each intermittent technique: computed tomographic perfusion (CTP)/Xenon-CT (Xe-CT), positron emission tomography (PET), magnetic resonance imaging (MRI), arteriovenous difference in oxygen (AVDO2) technique, thigh cuff deflation technique (TCDT), transient hyperemic response test (THRT), orthostatic hypotension test (OHT), mean flow index (Mx), and transfer function autoregulation index (TF-ARI). MEDLINE®, BIOSIS, EMBASE, Global Health, Scopus, Cochrane Library (inception to December 2016), and reference lists of relevant articles were searched. A two tier filter of references was conducted. The total number of articles utilizing each of the nine searched techniques for intermittent/semi-intermittent autoregulation techniques in adult TBI were: CTP/Xe-CT (10), PET (6), MRI (0), AVDO2 (10), ARI-based TCDT (9), THRT (6), OHT (3), Mx (17), and TF-ARI (6). The premise behind all of the intermittent techniques is manipulation of systemic blood pressure/blood volume via either chemical (such as vasopressors) or mechanical (such as thigh cuffs or carotid compression) means. Exceptionally, Mx and TF-ARI are based on spontaneous fluctuations of cerebral perfusion pressure (CPP) or mean arterial pressure (MAP). The method for assessing the cerebral circulation during these manipulations varies, with both imaging-based techniques and TCD utilized. Despite the limited literature for intermittent/semi-intermittent techniques in adult TBI (minus Mx), it is important to acknowledge the availability of such tests. They have provided fundamental insight into human autoregulatory capacity, leading to the development of continuous and more commonly applied techniques in the intensive care unit (ICU). Numerous methods of intermittent/semi-intermittent pressure autoregulation assessment in adult TBI exist, including: CTP/Xe-CT, PET, AVDO2 technique, TCDT-based ARI, THRT, OHT, Mx, and TF-ARI. MRI-based techniques in adult TBI are yet to be described, with the main focus of MRI techniques on metabolic-based cerebrovascular reactivity (CVR) and not pressure-based autoregulation.

Entities:  

Keywords:  adult TBI; autoregulation measurement; intermittent techniques; systematic review

Mesh:

Year:  2017        PMID: 28648106     DOI: 10.1089/neu.2017.5085

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  12 in total

1.  Association between Cerebrovascular Reactivity Monitoring and Mortality Is Preserved When Adjusting for Baseline Admission Characteristics in Adult Traumatic Brain Injury: A CENTER-TBI Study.

Authors:  Frederick A Zeiler; Ari Ercole; Erta Beqiri; Manuel Cabeleira; Eric P Thelin; Nino Stocchetti; Ewout W Steyerberg; Andrew I R Maas; David K Menon; Marek Czosnyka; Peter Smielewski
Journal:  J Neurotrauma       Date:  2019-12-30       Impact factor: 5.269

2.  Validation of Intracranial Pressure-Derived Cerebrovascular Reactivity Indices against the Lower Limit of Autoregulation, Part II: Experimental Model of Arterial Hypotension.

Authors:  Frederick A Zeiler; Jennifer K Lee; Peter Smielewski; Marek Czosnyka; Ken Brady
Journal:  J Neurotrauma       Date:  2018-08-10       Impact factor: 5.269

Review 3.  The Key Role of Magnetic Resonance Imaging in the Detection of Neurodegenerative Diseases-Associated Biomarkers: A Review.

Authors:  Ke-Ru Li; An-Guo Wu; Yong Tang; Xiao-Peng He; Chong-Lin Yu; Jian-Ming Wu; Guang-Qiang Hu; Lu Yu
Journal:  Mol Neurobiol       Date:  2022-07-12       Impact factor: 5.682

4.  Optimal cerebral perfusion pressure via transcranial Doppler in TBI: application of robotic technology.

Authors:  Frederick A Zeiler; Marek Czosnyka; Peter Smielewski
Journal:  Acta Neurochir (Wien)       Date:  2018-09-29       Impact factor: 2.216

5.  How I monitor cerebral autoregulation.

Authors:  Samuel P Klein; Bart Depreitere; Geert Meyfroidt
Journal:  Crit Care       Date:  2019-05-07       Impact factor: 9.097

6.  Validation of non-invasive cerebrovascular pressure reactivity and pulse amplitude reactivity indices in traumatic brain injury.

Authors:  Leanne A Calviello; András Czigler; Frederick A Zeiler; Peter Smielewski; Marek Czosnyka
Journal:  Acta Neurochir (Wien)       Date:  2019-12-18       Impact factor: 2.216

Review 7.  Association of Age and Sex With Multi-Modal Cerebral Physiology in Adult Moderate/Severe Traumatic Brain Injury: A Narrative Overview and Future Avenues for Personalized Approaches.

Authors:  C Batson; A Gomez; A S Sainbhi; L Froese; F A Zeiler
Journal:  Front Pharmacol       Date:  2021-11-24       Impact factor: 5.810

Review 8.  Non-Invasive and Minimally-Invasive Cerebral Autoregulation Assessment: A Narrative Review of Techniques and Implications for Clinical Research.

Authors:  Amanjyot Singh Sainbhi; Alwyn Gomez; Logan Froese; Trevor Slack; Carleen Batson; Kevin Y Stein; Dean M Cordingley; Arsalan Alizadeh; Frederick A Zeiler
Journal:  Front Neurol       Date:  2022-04-26       Impact factor: 4.086

9.  Application of robotic transcranial Doppler for extended duration recording in moderate/severe traumatic brain injury: first experiences.

Authors:  F A Zeiler; P Smielewski
Journal:  Crit Ultrasound J       Date:  2018-07-23

Review 10.  Transcranial Doppler Based Cerebrovascular Reactivity Indices in Adult Traumatic Brain Injury: A Scoping Review of Associations With Patient Oriented Outcomes.

Authors:  Alwyn Gomez; Logan Froese; Amanjyot Singh Sainbhi; Carleen Batson; Frederick A Zeiler
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.